NCT02605746View on ClinicalTrials.gov

Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 17, 2016

Primary Completion Date

November 29, 2018

Study Completion Date

July 12, 2019

Conditions
GlioblastomaBrain Metastases
Interventions
DRUG

ceritinib 750mg

Trial Locations (1)

85013

Barrow Brain and Spine, Phoenix

Sponsors

Collaborators (1)

Novartis
All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

Wayne State University

OTHER

collaborator

Translational Genomics Research Institute

OTHER

lead

St. Joseph's Hospital and Medical Center, Phoenix

OTHER

NCT02605746 - Preoperative Ceritinib (LDK378) in Glioblastoma Multiforme and CNS Metastasis | Biotech Hunter | Biotech Hunter